• SPX
  • $5,967.51
  • 0.32 %
  • $18.80
  • DJI
  • $44,190.11
  • 0.73 %
  • $319.75
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,262.08
  • 1.38 %
  • $112.81
  • IXIC
  • $18,994.31
  • 0.12 %
  • $21.89
Kura Oncology, Inc. (KURA) Competitors

Kura Oncology, Inc. (KURA) Competitors

NASDAQ Currency in USD Disclaimer

Stock Price

$10.86

$0.8

(7.95%)

Day's range
$9.95
Day's range
$11.17

Kura Oncology, Inc. Competitors

Symbol Company Share Price Market Cap P/E Ratio Employee Count Revenue
CERE
Cerevel Therapeutics Holdings, Inc. $44.96 $7.29 B -14.66 355 $0
COGT
Cogent Biosciences, Inc. $9.20 $802.20 M -3.37 164 $0
CRNX
Crinetics Pharmaceuticals, Inc. $56.06 $3.53 B -11.86 290 $4.01 M
DAWN
Day One Biopharmaceuticals, Inc. $13.80 $1.12 B -5.11 174 $0
DSGN
Design Therapeutics, Inc. $5.70 $217.51 M -3.7 54 $0
ERAS
Erasca, Inc. $2.77 $647.94 M -2.83 126 $0
GLUE
Monte Rosa Therapeutics, Inc. $8.63 $243.38 M -1.59 133 $0
GRCL
Gracell Biotechnologies Inc. $10.25 $989.87 M -10.57 314 $0
INZY
Inozyme Pharma, Inc. $2.70 $286.39 M -3.43 59 $0
KALV
KalVista Pharmaceuticals, Inc. $10.00 $492.76 M -3.74 150 $0
KNSA
Kiniksa Pharmaceuticals, Ltd. $21.28 $1.35 B 146.62 297 $270.26 M
LRMR
Larimar Therapeutics, Inc. $6.25 $611.84 M -9.99 42 $0
MRUS
Merus N.V. $46.60 $3.50 B -19.38 172 $43.95 M
PTGX
Protagonist Therapeutics, Inc. $44.45 $2.04 B 13.7 126 $60.00 M
REPL
Replimune Group, Inc. $15.82 $485.18 M -2.44 331 $0
SNDX
Syndax Pharmaceuticals, Inc. $15.76 $1.66 B -6.02 184 $0
THRX
Theseus Pharmaceuticals, Inc. $4.07 $181.50 M -3.03 38 $0
VRDN
Viridian Therapeutics, Inc. $19.98 $776.72 M -2.71 94 $314,000
ZNTL
Zentalis Pharmaceuticals, Inc. $3.38 $754.16 M -3.26 124 $0
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.